Glioblastoma-derived mechanisms of systemic immunosuppression

Neurosurgery Clinics of North America
Allen Waziri

Abstract

Abnormalities of cellular immunity are commonly seen in patients with glioblastoma (GBM), and the subsequent relative immunosuppression likely contributes to poor tumor-specific responses in affected individuals. Endogenous immune regulation is likely to limit the efficacy of a wide array of immunotherapeutic strategies, therefore mandating consideration in the continued development of novel treatments for GBM. Various tumor-associated factors have been implicated as potential generators of the immunosuppressive effect. This article outlines relevant experimentation exploring the nature of immune defects in patients with GBM, including a critical discussion of tumor-secreted factors, cell-surface proteins, and more recently described populations of immunoregulatory leukocytes that have potential roles in the subversion of cellular immunity.

References

Dec 1, 1987·Journal of Neurosurgery·T L RoszmanL H Elliott
Aug 1, 1987·Journal of Neurosurgery·L H ElliottT L Roszman
Jan 1, 1983·Journal of Neuro-oncology·G W Wood, R A Morantz
Mar 15, 1997·The Journal of Clinical Investigation·P SaasP Y Dietrich
May 30, 1998·Acta Neuropathologica·N HusainN T Zervas
Aug 13, 1998·Immunological Reviews·C A O'Callaghan, J I Bell
Jun 9, 1999·International Journal of Cancer. Journal International Du Cancer·S WagnerJ C Tonn
Mar 1, 2000·Journal of Neuroimmunology·A R DixL A Morford
Aug 24, 2001·Brain Tumor Pathology·M IchinoseK Tabuchi
Jan 10, 2002·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Richard C AndersonJeffrey N Bruce
Mar 9, 2002·Journal of Neurosurgery·Vladimir V DidenkoDavid S Baskin
Dec 25, 2003·Journal of Clinical Pathology·N NathooM Golubic
Jan 8, 2004·Seminars in Cancer Biology·Vera RebmannHans Grosse-Wilde
Jul 17, 2004·Cancer Research·Alan H ShihEric C Holland
Nov 4, 2004·International Journal of Cancer. Journal International Du Cancer·Jong Myun ParkJay A Berzofsky
Nov 19, 2004·Nature·Sheila K SinghPeter B Dirks
Mar 18, 2005·Annual Review of Immunology·Rebecca J GreenwaldArlene H Sharpe
Mar 24, 2005·Nature Immunology·Yasmine Belkaid, Barry T Rouse
Jun 24, 2005·Neuroreport·Rick WilmottePierre-Yves Dietrich
Dec 28, 2005·Seminars in Cancer Biology·Clare Baecher-Allan, David E Anderson
Jun 24, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Marcela AssanahPeter Canoll
Apr 3, 2008·Neurosurgery·Alfred T OgdenJeffrey N Bruce
Apr 12, 2008·Purinergic Signalling·Karen M DwyerSimon C Robson
May 31, 2008·Cell·Shimon SakaguchiMasahiro Ono
Jul 11, 2008·Immunological Reviews·Todd M BruskoJeffrey A Bluestone
Aug 14, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Amy B HeimbergerGregory N Fuller
Feb 20, 2009·BMC Immunology·Benjamin C KennedyJeffrey N Bruce
Feb 26, 2009·Immunity·Andreas StrasserShigekazu Nagata

❮ Previous
Next ❯

Citations

Nov 8, 2011·Cancer Immunology, Immunotherapy : CII·Sagar DandawatePrahlad Parajuli
Sep 4, 2012·Immunologic Research·Tullia C BrunoJill E Slansky
Aug 13, 2011·ASN Neuro·Leanne C HuysentruytThomas N Seyfried
Feb 7, 2012·Journal of Immunotherapy·Alexia GhaziNabil Ahmed
Aug 10, 2010·Journal of Neuroinflammation·Johan SöderlundRichard E Kast
May 6, 2011·Immunotherapy·Tony AvrilVéronique Quillien
May 1, 2013·Journal of Neuroimmunology·Kirsten HattermannRolf Mentlein
Mar 25, 2015·International Journal of Cancer. Journal International Du Cancer·Jeroen de VrijMarike L D Broekman
Dec 24, 2015·Vaccines·Katherine E Kunigelis, Michael W Graner
Jul 4, 2012·Neurosurgery Clinics of North America·Christopher JacksonMichael Lim
Mar 15, 2016·Frontiers in Surgery·Seyed-Mostafa RazaviGordon Li
Dec 30, 2015·Journal of Neuroimmunology·J Bryan IorgulescuAndrew T Parsa
Oct 30, 2015·Experimental Cell Research·Jacomijn P DijksterhuisGunnar Schulte
Aug 10, 2013·International Journal of Cancer. Journal International Du Cancer·Tina VerschuereSteven De Vleeschouwer
Sep 20, 2015·Neuro-oncology·Justin E HellwinkelMichael W Graner
Nov 5, 2014·International Journal of Cancer. Journal International Du Cancer·Astrid AuthierIan F Hermans
Jan 22, 2015·International Journal of Cancer. Journal International Du Cancer·Mi ZhouJohn K Wiencke
Jun 22, 2015·Journal of Neuro-oncology·Leonel AmpieAndrew T Parsa
May 26, 2016·Expert Opinion on Emerging Drugs·Rupen DesaiJohn H Sampson
Nov 12, 2016·Cancer Biology & Therapy·Kristen HaberthurCourtney A Crane
Nov 23, 2016·Cancer·Anastasie M Dunn-Pirio, Gordana Vlahovic
Oct 31, 2015·Neuro-oncology·David A ReardonLinda Liau
Mar 24, 2017·Brain : a Journal of Neurology·Candice C PoonJohn J P Kelly
Nov 16, 2011·Clinical Medicine Insights. Oncology·Manuel Nieto-SampedroManuel Nieto-Díaz
Sep 6, 2014·Neuro-oncology·David A ReardonGlenn Dranoff
Apr 3, 2013·Expert Review of Neurotherapeutics·Brian M AlexanderPatrick Y Wen
Jun 12, 2013·Expert Review of Vaccines·David A ReardonGlenn Dranoff
Oct 31, 2019·International Journal of Molecular Sciences·Jakub LitakJacek Roliński
Feb 9, 2017·BioMed Research International·Araceli Gutiérrez-RodríguezIgnacio Camacho-Arroyo
Mar 3, 2020·Current Pharmaceutical Design·Manish AdhikariMichael Keidar
Apr 17, 2015·Journal of Neuro-oncology·Kevin K H ChowGordon Li
Feb 12, 2017·Clinical Epigenetics·John K WienckeBrock C Christensen
Jul 19, 2018·Oncotarget·Shariq S KhwajaJiayi Huang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

Neurosurgery Clinics of North America
Emilia AlbesianoMichael Lim
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Jun WeiAmy B Heimberger
© 2022 Meta ULC. All rights reserved